Australian Entertainment Stock News

ASX:DRO
ASX:DROAerospace & Defense

Is DroneShield (ASX:DRO) Quietly Recasting Its Defence Credentials With Admiral Goddard’s Board Appointment?

DroneShield Limited has appointed retired Rear Admiral Lee Goddard CSC as an Independent Non-Executive Director, effective 1 July 2026, adding extensive defence, national security and governance experience to its board. Goddard’s deep involvement in government acquisition systems and international defence cooperation, particularly across Australia and the United States, could meaningfully influence DroneShield’s access to procurement programs and complex multi-agency customers. We’ll now...
ASX:LLC
ASX:LLCReal Estate

Is The Crown Estate Capital‑Light JV Reshaping The Investment Case For Lendlease Group (ASX:LLC)?

Lendlease recently launched a £24.00 billion regeneration joint venture with The Crown Estate, marking a shift toward a capital-light, fee-based development management model aimed at reducing balance sheet risk. This partnership could reshape how Lendlease earns development income, relying more on management fees and less on its own capital, which may alter the company’s risk and return profile over time. We will now examine how this capital-light Crown Estate joint venture might influence...
ASX:FFM
ASX:FFMMetals and Mining

FireFly Metals (ASX:FFM) Could Be 97% Undervalued As Green Bay Drilling Builds Momentum

FireFly Metals (ASX:FFM) has drawn fresh attention after reporting new drilling results at its Green Bay copper gold project, with high grade core zone assays feeding directly into upcoming economic studies. See our latest analysis for FireFly Metals. FireFly Metals' latest Green Bay results arrive after a mixed stretch in the market, with the share price up 5.21% over one day and 14.97% over seven days, yet down 15.79% over 30 days. Total shareholder return sits at 77.97% over one year and a...
ASX:IPX
ASX:IPXMetals and Mining

3 Australian Founder Led Stocks With Buybacks Data Centres And Critical Minerals Exposure

With inflation trends mixed across regions, policy signals shifting and long term yields staying elevated, many investors are looking for leaders who are directly invested in the outcomes of their decisions. Founder led companies often have that extra layer of commitment, with management focused on building legacies rather than just meeting quarterly targets. Our Founder Led Companies screener is designed to highlight businesses where the people in charge are materially tied to the long term...
ASX:JDO
ASX:JDOBanks

Judo Capital Holdings (ASX:JDO) Following Its FY26 Guidance Cut And Credit Risk Reset Is It Undervalued

Judo Capital Holdings (ASX:JDO) is back in the spotlight after cutting its FY26 profit before tax guidance and flagging higher credit risk linked to several problematic SME loan exposures. See our latest analysis for Judo Capital Holdings. The share price of Judo Capital Holdings has reacted sharply to the revised FY26 profit guidance and loan exposure issues, with a 30 day share price return down 38.46% and a year to date share price return down 51.11%. The 1 year total shareholder return is...
ASX:BGL
ASX:BGLMetals and Mining

Bellevue Gold (ASX:BGL) Enters Production As Fair Value Questions Come Into Focus

Bellevue Gold (ASX:BGL) has shifted from project development into active production, a step that has sharpened investor attention on its ramp up toward steady state output as gold prices remain supportive. See our latest analysis for Bellevue Gold. Bellevue Gold’s recent 5.14% 1 day share price return to A$1.33 follows a short term pullback, with the 30 day share price return down 11.92% and the year to date share price return down 21.76%. However, the 1 year total shareholder return of...
ASX:RWC
ASX:RWCBuilding

Shifting Brass Production Offshore Could Be A Game Changer For Reliance Worldwide (ASX:RWC)

Reliance Worldwide has closed its brass casting, forging and machining operations in Moorabbin and Braeside, Melbourne, plus smaller Australian sites, after a sustained decline in brass production volumes and a shift toward automated US manufacturing and third‑party sourcing in Asia. The move includes a largely non‑cash one‑off charge of about US$100 million–US$110 million in Fiscal Year 2026 but is expected to deliver an annual EBITDA benefit of roughly US$9 million across the group by the...
ASX:TCL
ASX:TCLInfrastructure

Is Transurban (ASX:TCL) Using Its Higher A$0.35 Payout To Recast Its Cash Flow Story?

Transurban Group previously announced a cash distribution of A$0.35 per stapled security for the six months ended 30 June 2026, with securities trading ex-distribution on 29 June 2026, a record date of 30 June 2026 and payment scheduled for 18 August 2026. This higher distribution underlines the importance of cash returns in Transurban’s total shareholder proposition, especially given its capital-intensive toll road portfolio. We’ll now examine how this higher A$0.35 distribution shapes the...
ASX:LTR
ASX:LTRMetals and Mining

Liontown (ASX:LTR) Back In Focus As Lithium Recovery Buzz Raises The Value Question

Why Liontown Shares Are Back in Focus Recent commentary has pushed Liontown (ASX:LTR) back into the spotlight as lithium recovery discussions gather pace and investors revisit battery material stocks with an eye on funding, offtake agreements, and project execution. This renewed attention places Liontown alongside other ASX lithium companies being assessed on project credibility rather than short term price momentum, which matters if you are weighing long term exposure to the spodumene...
ASX:ORI
ASX:ORIChemicals

Orica (ASX:ORI) Could Be 7% Undervalued After Hunter Valley Green Hydrogen Decision

Orica (ASX:ORI) has confirmed it will proceed with a commercial scale green hydrogen facility in the Hunter Valley, aiming to cut emissions by partially replacing natural gas feedstock within its existing operations. See our latest analysis for Orica. Orica's green hydrogen decision comes after a period where short term share price momentum has picked up, with a 90 day share price return of 18.56%, while the 1 year and 5 year total shareholder returns of 25.56% and 105.89% point to stronger...
ASX:JBH
ASX:JBHSpecialty Retail

JB Hi Fi (ASX:JBH) Draws Dividend Attention, Is The Valuation Debate Already Priced In?

Why JB Hi-Fi is back in focus for dividend investors JB Hi-Fi (ASX:JBH) is back on investors’ radar after recent coverage highlighted its dividend appeal alongside resilient sales, even as rising supplier costs and stronger competition keep retail sector margins under scrutiny. This renewed attention comes as income-focused investors weigh JB Hi-Fi’s cash flow profile and dividend record in the context of questions about discretionary spending, household budgets and the extent to which...
ASX:PXA
ASX:PXAReal Estate

Does PEXA Group’s (ASX:PXA) UK Co-CEO Move Reframe Its Regulatory And Expansion Risk Narrative?

PEXA Group recently announced a leadership reshuffle in its UK business, appointing Krystle Kocik and Simon Wright as Co-CEOs, alongside adding two independent non-executive directors, Janelle Hopkins and John Hooper, to its board. These leadership and governance changes, combined with PEXA’s engagement on IPART’s draft review of ELNO service fees, could reshape how investors assess its UK expansion and regulatory risk profile. We’ll now examine how the new Co-CEO structure in PEXA UK may...
ASX:ARU
ASX:ARUMetals and Mining

Arafura Rare Earths (ASX:ARU) After Its Supply Deal And Funding Progress, Is It Undervalued

Arafura Rare Earths (ASX:ARU) has attracted fresh attention after signing a binding term sheet to supply neodymium praseodymium oxide, and is moving toward final funding approvals and imminent construction at its Nolans Project. See our latest analysis for Arafura Rare Earths. At a share price of A$0.25, Arafura Rare Earths has seen a 7 day share price return of 6.38%, while the 30 day and 90 day share price returns are down 10.71% and 16.67% respectively. Over a longer period, the 1 year...
ASX:ELV
ASX:ELVMetals and Mining

Why Elevra Lithium (ASX:ELV) Is Up 10.3% After Fully Funding Its North American Expansion

Elevra Lithium has completed the groundbreaking of its North American Lithium Expansion project, following a May 2026 capital raise that fully funded Stage 1 and allowed equipment orders to support its planned development timeline. By targeting a 15–20% uplift in spodumene concentrate capacity and lower unit operating costs, the expansion underlines Elevra Lithium’s push to supply more traceable lithium to electric vehicle and energy storage customers. Next, we’ll examine how fully funded...
ASX:KCN
ASX:KCNMetals and Mining

Gold Mining Stocks Retail Investors Are Watching As Rate Cut Hopes Lift Gold

Gold mining stocks are back in focus after a key shift in the macro backdrop. Softer U.S. jobs data, reduced expectations for further Federal Reserve rate hikes and renewed central bank demand for bullion have all supported gold prices, giving fresh attention to companies that pull the metal out of the ground. For investors, that combination can change how risk and reward stack up across gold mining stocks screened for financial strength and specific country exposure. This article looks at 3...
ASX:APW
ASX:APWREITs

ASX Penny Stocks To Watch In July 2026

As the Australian market opens the new financial year flat, with the ASX hovering around 8,780 points, global markets are showing mixed signals amid ongoing geopolitical tensions and tech-driven rallies. In such a landscape, identifying promising investment opportunities requires a keen eye for stocks that balance affordability with potential for growth. Penny stocks, often representing smaller or newer companies, continue to capture investor interest due to their unique blend of...
ASX:TLX
ASX:TLXBiotechs

Telix Pharmaceuticals (ASX:TLX) Clears FDA Trial Step, Does It Look Fairly Valued?

Telix Pharmaceuticals (ASX:TLX) is back in focus after a Type B meeting with the U.S. Food and Drug Administration confirmed that safety data from its ProstACT Global Phase 3 trial supports moving TLX591-Tx into Part 2. See our latest analysis for Telix Pharmaceuticals. Alongside the FDA update, Telix Pharmaceuticals has drawn fresh attention after a strong 30-day share price return of 36.03% and year to date share price return of 51.23%. However, the 1-year total shareholder return declined...